Balloon dilation of severe aortic stenosis in the fetus: Technical advances  by Tworetzky, Wayne et al.
496A ABSTRACTS - Pediatric Cardiology JACC March 19,2003 
10:45 a.m. 
891-2 Quantifying Right Ventricular Regional Systolic 
Function: Tetralogy of Fallot Versus Normals Using 
Magnetic Resonance Imaging 1-D Myocardial Tagging 
Jondavid Men&r, Paul M. Weinberg, Mark Fogel, Children’s Hospital of Philadelphia, 
Philadelphia, PA 
Background: Right ventricular (RV) function is notoriously difficult to quantify. Previous 
studies of patients with Tetralogy of Fallot (TOF) have demonstrated decreased global 
systolic performance. To assess regional RV mechanics, we took advantage of MRl’s 
unique ability to tag myocardial tissue. Methods: By performing 1-D tissue tagging per- 
pendicular to the long axis in tine-MRI series in 4.chamber and RV long-axis views, we 
measured regional systolic shortening fractions (RSF‘s) of myocardium throughout the 
RV. We standardized twelve regions that can be assessed in these views, including three 
regions each along the RV free wall, the intelventricular septum (IVS). the superior RV 
wall toward the outflow tract, and the inferiorldiaphragmatic surface. The population 
included 13 normals and 6 patients with Tetralogy of Fallot (TOF) sip transannular patch 
repair, ages 2 months to 16 years. Using computer-assisted intensity mapping, regional 
shortening was measured in each of the specified regions. Results: In normals, areas 
with the smallest shortening fractions included the IVS near the atrioventricular canal 
(AVC) and the mid-IVS (20.5% and 18.1%). The most dynamic areas were the anterior 
free wall regions (near AVC 32% mid 33.1%, apex 35.7%) and the mid- and apical-infe- 
rior wall (30.1% and 30.8%). These two groups were significantly different from one 
another (P’s all <0.0002). The remaining regions had intermediate shortening. including 
the RV outflow tract (24.9%), inferior AVC (22.3%), superior midwall (28.2%), superior 
apex (26.6X+ and ssptal apex (23.1%). All regions had standard deviations of 4-9%. 
TOF patients had significantly decreased shortening in all mid-free wall regions (superior, 
anterior, and inferior) as well as in the anterior apical region (~~0.05). Conclusions: Our 
oreliminarv data shows that RSF’s can be measured in the RV usina 1-D mvocardial taa- 
sing. Are& of greatest fibrous tissue content such as the IVS and RV outf& tract tend 
to have the smallest RSF‘s. whereas free wall areas tend to have oreater RSF’s. TOF 
patients have decreased free wall shortening despite the volume load to their RV. consis 
tent with previous studies of global ejection fractions in TOF. 
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891-3 Balloon Dilation of Severe Aortic Stenosis in the Fetus: 
Technical Advances 
Wavne Tworehky, Russell W. Jennings. Louise E. Wilkins-Haug, Carol B. Benson, 
Audrey C. Marshall, Steven D. &Ian, Mary van der Velde, Stanton B. Perry, James E. 
Lock, Children’s Hospital Boston. Boston, MA, Brigham &Women’s Hospital, Boston, MA 
Introduction: It has been postulated that reduced flow through the left ventricle (LV) in 
utero, due either to inflow or outflow obstruction, can result in hypoplastlc left heart syn- 
drome (HLHS). Fetal intervention to relieve the valvar obstruction may prevent the devel- 
opment of secondary LV hypoplasia. Such therapeutic interventions require I) 
appropriate identification and selection of patients, 2) optimal timing of the procedure, 
and 3) safe and effective relief of the obstruction. All of these criteria depend on the 
development of a reliable and effective technical application. Methods: Since March 
2000, we have attempted to relieve aortic stenosis or atresia in 7 fetuses (22-29 weeks). 
At least three fetal echocardiographers concluded from the fetal ultrasound (U/S) that 
HLHS would be the most likely outcome at term birth. All fetuses had little or no flow 
across the stenotic aortic valve, Severe LV dysfunction, reversal of aorlic arch flow and 
either reversal or no flow across the foramen wale. All had some degree of increased LV 
echogenicity. Results: In all 7 patients, access was obtained by U/S guided puncture of 
the LV with a 19 gauge cannula and subsequent attempted wire/balloon manipulation 
across the aortic valve. In Group 1 (n=4) the fetus was positioned and the LV apex 
accessed percutaneously. All 4 fetuses had successful LV access, although wwballoon 
passage acmes the aortic valve and the establishment of increased antegrade flow suc- 
ceeded in only one fetus. That fetus was delivered at 34 weeks gestation and at 9 
months of age has mild aomc stenosis and good LV function. One fetus delivered 3 
weeks after the procedure at 25 weeks gestation and died. The other two were born with 
HLHS. In Group 2 (n=3) the uterus was exposed via a lower transverse laparotomy, 
enabling substantially improved U/S visualization, fetal positioning and cannula manipu- 
lation. All 3 procedures were technically successful. One fetus with severe hydrops and 
cardiomegaly died within 24 hours; the other two have increased antegrade flow. 
improved LV function and are still in utero. Conclusion: Laparotomy and uterine exposure 
may improve technical success in performing therapeutic cardiac interventions ln the 
fetus. 
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891-4 Clinical Role and Technical Aspects of Cardiac 
Magnetic Resonance Imaging in Infancy 
Beverlv Tsai-Goodman. Tal Geva, Kirsten Odegard, Laureen Sena, Andrew J. Powell, 
Children’s Hospital Boston, Boston, MA 
Background: MRI has been demonstrated to be an important non-invasive diagnostic 
modality in patients with congenital heart disease; however, few studies have focused on 
young children. This study examined the clinical utility and technical challenges of cardio- 
vascular MRI in infants. 
Methods: All patients age <l year undergoing cardiac MRI at Children’s Hospital Boston 
between January 1999 and July 2002 were identified and their MRI records and clinlcal 
data were retrospectively reviewed. 
Results: A total of 62 MRI studies (63% in-patients) were performed in 76 patients at a 
median age of 102 days (range l-358 days) and with a median weight of 5.0 kg (range 
1.2-16.3 kg). All examinations were performed under general anesthesia using either a 
head (n=48). cardiac (n=l8). shoulder (n=l3), or 5” surface (n=3) RF receiver coil. No 
clinical decompensation or other complications occurred. The majority of studies (84%) 
were performed pre-operatively. Referral questions were pulmonary artery anatomy 
(n=l6), aortic anatomy (n=l I), vascular ring anatomy (n=12), airway compression 
(n=lO), pulmonary venous anatomy (n=lO), cardiac tumor (n=7), aorta-pulmonary collat- 
erals (n=4) and other (n=l2). Prior investiaations for these auestions included echocar- 
diography (70%), cardiac catherization (lo%), bronchoscopy (7%), CT scan (2%). or 
TEE (1%). MRI rxovided the reouested diaanostic information in all studies. Furthermore. 
in 15182 (18%) examinations, MRI yielded an addittonal unsuspected diagnosis. Findings 
at surgery (n=42) and cardiac catherization (n=lO) were all concordant with those found 
by MRI. Systematic review demonstrated that airway anatomy was best shown with fast 
spin echo sequences and the thoracic vasculature by Gadolinium-enhanced 3D MR 
angiography. 
Conclusion: Cardiac MRI is a useful and safe imaging modality in assessing thoracic 
vasculature and airway anatomy in infants with congenital heart disease. In some cases, 
it obviates the need for cardiac catherization or bronchoscopy. 
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891-5 Secondary Prevention of Cerebrovascular Events in 
Patients With Patent Foramen Ovale and Cryptogenic 
Stroke: AUSTRIAN-PFO-Registry 
Hernia W. Schuchlenz Reinhold Schmidt, Wolfgang Weihs, Anita Lechner, 
P.Medizlnische Abteilung, LKH-Graz. Graz, Austria, Universltfitsklinik fiir Neurologie, 
Graz, Austria 
Background: Paradoxical embolism is a well recognfzed cause of stroke. Treatment 
options are antiplatelet therapy, anticoagulation and ckxure of patent foramen wale. 
However, therapy for patent foramen wale (PFO) remains controversial. There are no 
accepted recommendations or guidelines for secondary prevention of cryptogenic stroke 
in pts with PFO. 
Methods: We undertook a 7.year observation study I” 286 pts with PFO and a cryptoge- 
nit cerebrovascular event (mean age 44*1 lyears). Treatment options were antiplatelet 
therapy, oral anticoagulation with an target international normalized ratio (INR) range of 
2.5 to 3.5, or interventional catheter-closure of the PFO. 
Results : During a 7.year follow up of 288 pts (788.6 patient-years), 38 recurrent cere- 
brovascular events occurred. Antiplatelet therapy was established in 73 pts. oral antiko- 
agulation in 21 lpts and interventIonal closure of the PFO was perlormed in 205 pts. The 
overall recurrence rate was 16.5%/patienWyear (95% Cl 9.5 to 27). Recurrent cere- 
brovascular events events occurred most frequent in pts with antiplatelet therapy (13%l 
patient/year; 95% Cl 8.32 to 19.3). The recurrence rates were significantly lower (~~0.05) 
in pts on oral anticoagulation 2,7%/patient/year (95%CI 1 .O to 5.58) or after interventional 
PFO-closure, O.B7%/patientlyear (95%CI 0.18-2.54).Target range of oral anticoagulation 
( INR.2.5 to 3.5 ) was achieved in 90%. Conclusion: Oral anticoagulation (INR 2.5-3.5) 
is superior to antiplatelet therapy and achieves comparable outcomes with interventional 
closure of PFO for secondary preventlon of recurrent cerebrovascular events in patients 
with PFO and cryptogenic stroke. 
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891-6 Mild Aortic Valve Insufficiency: A Mid-Term 
Complication of Percutaneous Closure of Atrial Septal 
Defects and Patent Foramen Ovale 
Steffen Schoen, Mathias Schulze, Stefan Lange, Steffen Bohl, Martin U. Braun, Ruth H. 
Strasser, University of Dresden, Dresden, Germany 
Background: Percutaneous transcatheter closure of atrial septal defects (ASD) or 
patent foramen wale (PFO) is used as an alternative to medical therapy or heart sur- 
gery. Focus of follow-up studies after implantation were procedural success, degree of 
residual interatrial shunts and recurrence rate of thromboembolic events. Although a sig- 
nificant deterioration of the aortic root and the mitral valve resulting in aoriic and mitral 
regurgitation was described after surgical closure of ASD, to our knowledge, no study 
investigated the mid-term functional and structural effects on the aortic and mitral valve 
caused by the implanted closure device. 
Methods: 86 patients underwent percutaneous closure of ASD or PFO with a double 
umbrella closure device (Card& PFO-Star or Amplatz Septal Occluder). ASD were 
secundum type defects with a mean size of 15 mm (8 to 22 mm) measured by transe- 
sophageal echocardiography (TEE). Percutaneous closure of PFO was performed in 
patients with cryptogenic cerebrovascular embolism. 
Results: A primarily successful implantation procedure could be performed in over 95%. 
TEE three months after implantation revealed suffizient closure without residual shunt in 
84% of patients with ASD and in 88% of patients with PFO. Compared with TEE flndings 
pre implantation, no increase in mitral or aortic regurgitation (AR) was found. However, a 
follow-up study six month after closure demonstrated an increase of AR in 4 patients with 
ASD (13%) and in 9 patients with PFO (18%). the AR jets emerged in the center of the 
aortic valves and ranged from mild (77%) to moderate (23%) in patients having no or 
minimal AR before implantation. No significant changes on mitral valve function were 
found. 
Conclusion: Six month after closure of ASD or PFO with a double umbrella device, TEE 
revealed mild AR in 13% of closed ASD and in 16% of closed PFO. A possible reason for 
devaloplng AR is traction on the root of the non coronary aortic cusp caused by the 
umbrella endothellalisation process shortening the aortic rim of the atrial septum. 
